28/10/26

A little bit more than a year ago, BioPitch published its first interview with Edwin Moses. Since then, the idea behind every piece has stayed the same: to cultivate a community where biotech entrepreneurs, investors and scientists can connect, gain insights, and forge the relationships needed to turn groundbreaking science into life-changing therapies.

On 28 October, that community steps off the screen and into a room. BioPitch and EY are co-hosting the first edition of BioTech Connect at EY Wavespace in Amsterdam. On the programme: an interview with Tim Knotnerus (CEO) and Paul van der Horst (CBO) of Agomab, and a panel on the future of biotech funding with Jan De Kerpel (Head of Life Sciences, Van Lanschot Kempen), Mariette Roesink (Founding Partner, Curie Capital) and an experienced biotech CEO.

Access is subject to approval by the organizers. To request a ticket, use the link in the top right to contact Yilmaz Bitter.

door Dina Diek